InstalabSLE Comprehensive Diagnostic Panel
Should you take a SLE Comprehensive Diagnostic Panel test?
This test is most useful if any of these apply to you.
11 biomarkers included
- Complement C3Tracks a blood protein consumed when antibody clusters turn on the complement chain.Why it mattersFalling C3 is one of the more reproducible blood warnings for kidney flare risk.
- DNA (DS) AntibodyDetects antibodies against your own double-stranded DNA. This is the most lupus-specific marker here and is tied to kidney risk.Why it mattersA positive result carries heavy diagnostic weight and should send you to a urine protein check.
- Complement C4Tracks an earlier part of the same complement chain as C3, helping separate broad complement use from one low protein.Why it mattersLow C4 plus low C3 strengthens the active-lupus pattern, but it is not unique to lupus.
- Chromatin AntibodyDetects antibodies to DNA wrapped in packaging proteins, adding a second nuclear target when anti-DNA is negative.Why it mattersIn quiet lupus, chromatin or nucleosome positivity can flag higher kidney-relapse risk.
- RNP AntibodyRibonucleoprotein (RNP) antibody marks overlap disease patterns, especially Raynaud symptoms and pressure changes in the lung arteries.Why it mattersA high RNP result redirects attention toward connective-tissue overlap and lung-circulation screening.
- Total ComplementChecks whether the classic complement chain works from start to finish, which C3 and C4 levels cannot show alone.Why it mattersA near-absent result with ordinary C3 and C4 can suggest an inherited missing complement component.
- ANA ScreenThe gate test. It looks for antinuclear antibodies (ANA), and a negative result makes lupus much less likely.Why it mattersA positive screen opens the question. By itself, it is too common in people without lupus to prove disease.
- ANA TiterReflexMeasures how far your blood can be diluted and still react. It turns a yes-or-no screen into a graded signal.Only run if your ANA Screen is positive.Why it mattersThe higher the dilution that still reacts, the less likely a common immune quirk explains your result.
- ANA PatternReflexShows how antinuclear antibodies light up cells under the microscope, which can steer which specific antibody result matters most.Only run if your ANA Screen is positive.Why it mattersA homogeneous pattern points toward DNA or chromatin targets; other patterns push the workup toward overlap disease.
- SS-A AntibodySjögren's syndrome A (SS-A) antibody connects the panel to dry eyes, dry mouth, sun-triggered rash, and pregnancy monitoring.Why it mattersIf pregnancy is possible, SS-A positivity calls for fetal heart monitoring.
- SS-B AntibodySjögren's syndrome B (SS-B) antibody often travels with SS-A and strengthens the dryness-pattern signal.Why it mattersPositive with SS-A, it shifts the pattern toward dryness and neonatal-lupus risk rather than kidney risk.
About SLE Comprehensive Diagnostic Panel
No single blood test diagnoses lupus. That is why symptoms that seem to belong together, aching joints, rash, mouth sores, exhaustion, can get handled as separate complaints for years. This panel is one of the standard ways to sort the question, but it still has to be read with symptoms, urine testing, and an exam.
It asks two things at once: what your immune system has built antibodies against, and whether complement proteins are being used up. The antibody tests help name the pattern. Complement helps show whether that pattern may be active now.
What This Panel Reveals
The screen comes first, and it is deliberately sensitive. It looks for antibodies aimed at material inside your own cell nuclei. Cell nuclei are the control centers that hold your DNA. This is why the test is called an antinuclear antibody test, or ANA.
At a screening dilution of 1:80, ANA is positive in 97.8% of people with lupus, and also positive in about one in four people without it. The titer is how that signal gets sorted. At 1:320, only about 3 in 100 people without lupus still react, but about one in seven people with lupus are missed.
A positive ANA tells you little by itself. The specific antibodies do more of the naming. Antibodies against double-stranded DNA are one of the strongest blood findings for lupus. Under the current international classification criteria, that finding is worth 6 points; 10 points classifies lupus for research. Anti-DNA shares that 6-point antibody group with anti-Smith, and only the highest-scoring item in a group counts, so carrying both does not double the score. Classification rules are not the same as diagnosis.
Chromatin antibodies add a second look at a related target: DNA wrapped around its packaging proteins. In one retrospective five-year study of people with lupus, chromatin was positive while anti-DNA was negative in 16% of paired samples. That figure comes from a single center, but the broader point holds: the two tests overlap without being duplicates.
Complement is where the panel shifts from identity to activity. C3 and C4 are blood proteins used in an immune chain reaction. When antibody clusters turn that chain on, C4 and C3 can be used up faster than the body replaces them. A low level is not proof that you have lupus. It is evidence that immune activity may be running.
Total complement asks a different question: can the complement chain run from start to finish? A very low result while C3 and C4 look ordinary can point to an inherited missing complement part rather than current use-up. That matters because inherited deficiency of early complement proteins is a known lupus risk factor.
How to Read Your Results Together
Sjögren's syndrome A antibody is SS-A. Sjögren's syndrome B antibody is SS-B. Ribonucleoprotein antibody is RNP. Most results fall into a few patterns.
| What You See | What It Points To |
|---|---|
| High titer, anti-DNA positive, C3 and C4 both low | Strong active-lupus pattern, especially if symptoms fit. Check urine protein now, because blood antibodies cannot tell you whether the kidney is involved. |
| Positive ANA, SS-A and SS-B positive, complements normal | A Sjögren-type or subacute skin-lupus pattern: dry eyes and mouth, sun-sensitive rash. Changes pregnancy monitoring more than kidney risk. |
| Positive ANA, high RNP, fingers that blanch in the cold | Overlap-pattern territory. Pressure in the lung arteries becomes worth checking if symptoms fit. |
| Low-titer ANA, all specific antibodies negative, complements normal | More often a nonspecific antibody pattern than lupus. Symptoms and repeat clinical findings decide whether it deserves follow-up. |
The pair worth watching hardest is anti-DNA plus low C3. In one study that followed 98 people for about three years, high anti-DNA or low C3 each pointed to lupus correctly 94% of the time in a population already being evaluated for it. When both were present, every person in that study had lupus. That is a useful signal from a small, enriched 1983 cohort, not a rule of nature.
Discordance is also useful. Chromatin positive with anti-DNA negative is not a contradiction. It is a second view of a related nuclear target.
What to Do with Your Results
If anti-DNA is positive or either complement protein is low, the next test is urine protein. Kidney involvement in lupus can be silent early, and it changes treatment. Get a urine albumin-to-creatinine ratio or urine protein-to-creatinine ratio without waiting.
Then track the markers that move: anti-DNA, C3, C4, and urine protein. Low C3 was linked to about triple the kidney-flare risk in pooled trial data. In clinically quiet lupus, chromatin or nucleosome antibodies marked a kidney-relapse rate of 38.9% over a year, compared with 13.4% without them. Keep drawing anti-DNA even if it has been positive all along: in a cohort of 3,484 people, changes on repeat testing still predicted flares in persistently positive patients.
SS-A and SS-B behave differently. They are closer to a one-time map of which autoimmune pattern you carry, and serial testing finds them the most stable antibodies in this group. In one clinic series, 89.4% of people had no change at all on repeat testing of extractable nuclear antigen antibodies. RNP is less fixed than that average suggests: newer serial data show it can turn negative over time at rates closer to anti-DNA, so treat a single RNP result as a starting point rather than a permanent label.
When Results Can Be Misleading
- A negative ANA does not fully close the door. In an international cohort of 1,137 newly diagnosed people with lupus, 6.2% had no detectable cell-staining antibodies on the screening test. That is a best-case figure from people at diagnosis; negative screens are reported more often in people already on treatment.
- Complement proteins can rise with general inflammation as well as fall from use-up, so a normal C3 during an obvious flare is not reassurance by itself.
- Some people run a low C4 for genetic reasons. A stable low C4 with normal C3 and no symptoms may simply be your baseline.
- Steroids and immune-suppressing drugs can lower antibody levels and let complement recover, so blood drawn after treatment starts describes the treated state.
- Anti-DNA methods do not produce interchangeable numbers. Run repeats at the same lab, or you may chase changes that are only lab differences.